Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

rebamipide; nanocrystals; oral mucositis; hydrogel; endocytosis; enoxaparin; lipid–polymer hybrid nanoparticles; oral; intestinal absorption; naftidrofuryl oxalate; solubility; permeability; dissolution profiles; pharmaceutical availability; BCS drug classification; non-sink condition; solubility–permeability interplay; unstirred water layer; poorly soluble drugs; solubilizer additive; phenylketonuria; l-phenylalanine ammonia-lyase; enzyme; kinetics; catabolism disorder; biomedical drug; P-glycoprotein; breast cancer resistance protein; LY335979; WK-X-34; in vivo–in vitro correlation; lipolysis-permeation; lipid-based drug delivery system; PermeaPad; cinnarizine; lipolysis; amorphous solid dispersion; candesartan Cilexetil; PVPK30; pH-modulation; spray drying; bioavailability; nasal administration; spray-drying; chitosan; microsphere; meloxicam; silymarin; D-α-Tocopherol polyethylene glycol 1000 succinate (TPGS); liver distribution; acetaminophen-induced hepatotoxicity; extra virgin olive oil; secoiridoids; metabolism; phenolic compounds; intestinal permeability; drug-phytochemical interaction; hepatic metabolism; mixed inhibition; quercetin; repaglinide